Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines ...
See the charts that show why Moderna's vaccine may offer protection longer than Pfizer and J&J's shots; This person stayed at a free 10-day quarantine hotel in NYC when they got COVID-19 ...
Booster doses are most recommended for adults age 65 and up, who don't generally have the same kind of strong, lasting immune response to vaccines as younger people. More evidence is beginning to ...
Hosted on MSN2mon
Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027Moderna said it plans to cut $1.1 billion in expenses by 2027 as it charts a path forward after the rapid decline of its Covid business. The biotech company said it expects 10 new product ...
It's been a sad week for Moderna, Inc. ( NASDAQ:MRNA ), who've watched their investment drop 14% to US$46.83 in the... On Thursday, Moderna Inc. (NASDAQ:MRNA) reported third-quarter revenue of $1. ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback